Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP KFPs / SAQswomens-health

GP KFPs / SAQs · womens-health

Urinary incontinence in women — KFP-style written assessment

KFP-style staged scenarios on urinary incontinence in women: sorting stress from urgency patterns, the conservative ladder with PRIDE and PFMT evidence, OAB pharmacotherapy choice, and the disclosure gap.

30 marks45 min4 min readVerification in progress

Target exams

RACGP KFPRACGP AKTMRCGP AKT
On this page
Study tools

Target exams

RACGP KFPRACGP AKTMRCGP AKT
Prompt
Urinary incontinence: ask, sort the pattern, run the ladder — stress, urgency, and the drugs that belong to urgency only

KFP 1 (10 marks)

A 52-year-old woman attends about her blood pressure. When you ask directly — because her intake questionnaire flagged "bladder problems" — she describes leaking when she coughs, laughs and lifts at her warehouse job since her second vaginal birth. It happens most days. Her BMI is 34. She has never mentioned it to anyone. [1] [9]

  1. What is the likely pattern, and what does the evidence say about how common her silence is? (3) [1]
  2. What conservative management would you start today, with quantitative evidence for each element? (4) [18] [3]
  3. She asks whether she will "need the mesh operation". How do you counsel her? (3) [26] [19]

Model answers

  1. Stress urinary incontinence (leakage with cough, laugh, exertion, no urgency). Her silence is the norm: only 26% of incontinent women have ever consulted a doctor about it, and even among women with significant troublesome incontinence only half have sought care. Asking directly is the intervention. [1]
  2. Three elements with evidence: (1) Pelvic floor muscle training — effective versus no treatment per Cochrane; the foundation, practised three months with supervision or a digital programme (real-world adherence 89%, improvement 74%). (2) Weight loss — in PRIDE, an 8% weight reduction over six months cut incontinence episodes by 47% versus 28% with education control, with the stress component falling most; at BMI 34 this is her highest-yield intervention. (3) Caffeine moderation as adjunct. Review at six to twelve weeks. [18] [3] [15]
  3. Surgery exists and works but is not now: conservative management for at least three months is the guideline standard, and only 54.1% of referrals currently meet that criterion. If she needs it later, midurethral slings are safe and effective with low long-term complication rates; the retropubic (TVT) route shows better long-term durability while the transobturator route carries more chronic groin/pelvic pain; mesh-free autologous options exist. The mesh debate is real but should not scare her out of a treatment that might help. [26] [19] [24]
General Practice Pro

Continue reading

You have read the opening of this kfps / saq. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References32ShowHide
  1. [1]Hannestad YS, Rortveit G, Hunskaar S Help-seeking and associated factors in female urinary incontinence. The Norwegian EPINCONT Study. Epidemiology of Incontinence in the County of Nord-Trøndelag Scand J Prim Health Care, 2002.PMID 12184708
  2. [2]Irwin DE, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol, 2006.PMID 17049716
  3. [3]Subak LL, et al. Weight loss to treat urinary incontinence in overweight and obese women N Engl J Med, 2009.PMID 19179316
  4. [4]Hashim H, Al Mousa R Management of fluid intake in patients with overactive bladder Curr Urol Rep, 2009.PMID 19863853
  5. [5]Irwin DE, et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction BJU Int, 2011.PMID 21231991
  6. [6]Visco AG, et al. Adherence to Oral Therapy for Urgency Urinary Incontinence: Results from the Anticholinergic Versus Botox Comparison (ABC) Trial Female Pelvic Med Reconstr Surg, 2016.PMID 26516810
  7. [7]Moyson J, et al. [Efficacy and safety of available therapies in the management of idiopathic overactive bladder: A systematic review of the literature] Prog Urol, 2017.PMID 28228331
  8. [8]Araujo CC, Marques AA, Juliato CRT The Adherence of Home Pelvic Floor Muscles Training Using a Mobile Device Application for Women With Urinary Incontinence: A Randomized Controlled Trial Female Pelvic Med Reconstr Surg, 2020.PMID 30624250
  9. [9]Lamerton TJ, Mielke GI, Brown WJ Urinary incontinence in young women: Risk factors, management strategies, help-seeking behavior, and perceptions about bladder control Neurourol Urodyn, 2020.PMID 32805080
  10. [10]Keyser LE, et al. A digital health program for treatment of urinary incontinence: retrospective review of real-world user data Int Urogynecol J, 2023.PMID 35969249
  11. [11]Kennelly M, et al. Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis Drugs Context, 2022.PMID 36303599
  12. [12]Kakkar A, et al. Adverse events associated with pessary use over one year among women attending a pessary care clinic Int Urogynecol J, 2023.PMID 36715742
  13. [13]Park J, et al. Effectiveness of Fluid and Caffeine Modifications on Symptoms in Adults With Overactive Bladder: A Systematic Review Int Neurourol J, 2023.PMID 37015722
  14. [14]Vasudeva P, et al. Autologous versus synthetic midurethral transobturator sling: A systematic review and meta-analysis of outcomes Neurourol Urodyn, 2024.PMID 38873955
  15. [15]Hall E, et al. Real-World Evidence From a Digital Health Treatment Program for Female Urinary Incontinence: Observational Study of Outcomes Following User-Centered Product Design JMIR Form Res, 2024.PMID 38935967
  16. [16]Kaga K, Mikami K, Kaga M Utilizing Bladder Diaries to Prevent Unnecessary Treatment in Patients With Storage Dysfunction: A Retrospective Study Cureus, 2024.PMID 39360064
  17. [17]MacArthur C, et al. Antenatal pelvic floor muscle exercise intervention led by midwives in England to reduce postnatal urinary incontinence: APPEAL feasibility and pilot randomised controlled cluster trial BMJ Open, 2025.PMID 39832969
  18. [18]Fernandes ACN, et al. Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women Cochrane Database Syst Rev, 2025.PMID 40066950
  19. [19]Thuillier C, et al. Why should we stop implanting transobturator sling? Fr J Urol, 2025.PMID 40250730
  20. [20]Cassé A, et al. State of knowledge on the specialized management of urinary incontinence and pelvic organ prolapse among general practitioners in Western France in the current mesh controversy era Fr J Urol, 2025.PMID 40447261
  21. [21]Getaneh FW, Sussman RD, Iglesia CB Nocturia: Evaluation and Management Am Fam Physician, 2025.PMID 40531150
  22. [22]Porcari I, et al. Vulvovaginal estrogen therapy for urinary symptoms in postmenopausal women: a review and meta-analysis Climacteric, 2026.PMID 40569036
  23. [23]Porto MG, et al. Urinary incontinence severity: the impact on workplace productivity World J Urol, 2025.PMID 40646280
  24. [24]Hasan M, et al. Long-Term Outcomes and Recurrence Rates of TVT versus TVTO in Female Stress Urinary Incontinence: A Systematic Review of Studies with ≥5-Year Follow-Up Int Urogynecol J, 2025.PMID 40844543
  25. [25]Vesentini G, et al. Interventions for treating urinary incontinence in older women: a network meta-analysis Cochrane Database Syst Rev, 2025.PMID 41307301
  26. [26]Banerjee I, et al. Quality and associated factors of guideline-concordant primary care referral for urinary incontinence and pelvic organ prolapse: A single centre retrospective observational study Eur J Obstet Gynecol Reprod Biol, 2026.PMID 41849977
  27. [27]Trikhacheva AS, et al. IncobotulinumtoxinA Versus OnabotulinumtoxinA for Treatment of Overactive Bladder Syndrome: A Randomized Single-blinded Non-inferiority Trial Urology, 2026.PMID 41933558
  28. [28]Liu J, et al. Electromyographic biofeedback-assisted pelvic floor muscle training for female stress urinary incontinence: a systematic review and meta-analysis Front Med (Lausanne), 2026.PMID 42445160
  29. [29]Mohamed-Ahmed R, Rantell A, Robinson D Comparing the safety and efficacy of vibegron, mirabegron and tolterodine in patients with overactive bladder: a systematic review and network meta-analysis Eur J Obstet Gynecol Reprod Biol, 2026.PMID 42501511
  30. [30]Salman MFA, et al. Autologous Transobturator Fascia Lata Sling for Female Stress Urinary Incontinence: A Pilot Feasibility and Safety Study Low Urin Tract Symptoms, 2026.PMID 42521462
  31. [31]Sangsawi P, Aree-Ue S, Roopsawang I Exploring the Link of Psychological Adaptation, Socio-Economic Status, and Symptom Types on Quality of Life in Community-Dwelling Older Women With Lower Urinary Tract Symptoms J Prim Care Community Health, 2026.PMID 42526051
  32. [32]Kaya H, et al. Effect of Second Sling Type on the Success of Repeat Procedures Urogynecology (Phila), 2026.PMID 42593896
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousMenopause and HRT — KFP-style written assessmentwomens-healthNextAcute rheumatic fever and RHD - KFP-style written assessmentaboriginal-and-torres-strait-islander-health